Session

Back to Programme Overview

Kidney transplant and urological cancer

Meeting of the EAU Section of Transplantation Urology (ESTU) in cooperation with the EAU Section of Oncological Urology (ESOU)

  • Location:
    Room Berlin, North Hall (Level 1)
  • Chairs:
     M. Brausi, Modena (IT)
     E. Lledó García, Madrid (ES)
  • Aims and objectives of this session

    Malignancy has become one of the three major causes of death after transplantation in the past decade and is thus increasingly important in all organ transplant programs. The objective of this session is to update real incidence and therapeutic aspects of urological cancers in both candidates and kidney transplant receptors.

Welcome and introduction
 
 M. Brausi, Modena (IT)
 
 E. Lledó García, Madrid (ES)
Prostate cancer in donors and KT candidates
 
Moderator:
 P. Ditonno, Bari (IT)
Screening of prostate cancer in donors: When?
 A. Chkhotua, Tbilisi (GE)
The receptor: Time to wait after the diagnosis and treatment. Any place for observational management?
 J.D.J.M. Branchereau, Nantes (FR)
Main surgical considerations in pre-transplant treatment of prostate cancer
 A. Breda, Barcelona (ES)
Conclusions
Prostate cancer in KT receptors
 
Moderator:
 F.J. Burgos Revilla, Madrid (ES)
PSA screening in KT recipients
 A.J. Figueiredo, Coimbra (PT)
Main surgical considerations in radical prostatectomy in KT receptors
 X.P.C. Tillou, Caen (FR)
Role of focal therapy in KT receptors
 J.I. Martínez Salamanca, Madrid (ES)
Conclusions
Oligometastatic prostate cancer in ESRD and KT patients
 
Moderator:
 C. Hernández Fernández, Madrid (ES)
 
 M. Brausi, Modena (IT)
Key technical aspects in the surgical approach of big retroperitoneal masses with vascular invasion
 
Moderator:
 F.J. González Garcia, Madrid (ES)
 
 G. Ciancio, Miami (US)
Special considerations in immunosuppresive protocals in KT patients with urological tumours
 
Moderator:
 F. Kleinclauss, Besançon (FR)
 
 K. Budde, Berlin (DE)
Renal cancer
 
Moderator:
 J.D. Olsburgh, London (GB)
How to deal with the small tumour in kidney donors?
 M. Musquera Felip, Barcelona (ES)
Management of kidney graft tumours in KT recipients: Sparing treatment versus radical surgery - Key aspects and indications
 V. Hevia Palacios, Madrid (ES)
Conclusions
Urothelial cancer
 
Moderator:
 J.A. Witjes, Nijmegen (NL)
An algorithm of management of non-muscle invasive urothelial cancer in kidney transplant receptors
 O. Rodriguez Faba, Barcelona (ES)
Management of muscle invasive urothelial cancer in kidney transplant receptors: Key aspects
 J. Palou, Barcelona (ES)
ESRD patient with history of urothelial cancer: Criteria to access the transplant waiting-list
 R. Boissier, Marseille (FR)
Conclusions
Presentation of the collaboration project for international specialisation in kidney transplant: ESTU-EAU and Jackson Memorial Hospital (Miami, USA)
 
 G. Guerra, Miami (US)
 
 E. Lledó García, Madrid (ES)
ESTU Research Grant Delivery Act
 
 E. Lledó García, Madrid (ES)
Presentation of the Renal Transplant Textbook (ESTU-EAU)
 
 A.J. Figueiredo, Coimbra (PT)
 
 E. Lledó García, Madrid (ES)
René Küss Lecture: De novo functional renal graft carcinomas - Are they a different entity
 
 X.P.C. Tillou, Caen (FR)
Rene Küss Award 2017
 
 E. Lledó García, Madrid (ES)
Conclusions
 
 M. Brausi, Modena (IT)
 
 E. Lledó García, Madrid (ES)